Performance of renal Doppler to predict the occurrence of acute kidney injury in patients without acute kidney injury at admission.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
06 2022
Historique:
received: 06 09 2021
revised: 13 12 2021
accepted: 31 12 2021
pubmed: 26 1 2022
medline: 4 5 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

This study aimed at evaluating the performance of Doppler-based resistive index (RI) and semi-quantitative evaluation of renal perfusion using color-Doppler (SQP) to predict de novo AKI in the subgroup of critically ill patients without AKI at admission. This study is an ancillary analysis of a prospective multicenter cohort study. Consecutive ICU patients requiring mechanical ventilation were included. Renal Doppler was performed at ICU admission. The diagnostic performance of RI and SQP to predict de novo AKI at day 3 was evaluated. Among the 371 patients of the prospective cohort, 118 without AKI at study inclusion were included. Thirty-four patients (29%) developed an AKI. Neither RI (0.64 UI [0.57-0.70] vs 0.67 [0.62-0.70] in no AKI and de novo AKI group respectively, p = 0.177) nor SQP (2 [2, 3] vs 2 [1-3] in no AKI and de novo AKI group respectively, p = 0.061) were associated with AKI occurrence. Overall performance in predicting de novo AKI was null to poor with area under ROC curve of respectively 0.60 (95% CI 0.49-0.65) and 0.58 (95% CI 0.47-0.60) for RI and SQP. Similar results were obtained after adjustment for confounders. These results confirm the poor performance of Doppler-based indices in predicting renal prognosis of ICU patients.

Identifiants

pubmed: 35074631
pii: S0883-9441(22)00001-6
doi: 10.1016/j.jcrc.2021.12.017
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02355314']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

153983

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest M.D. declare having received administrative support from his former institution (Saint-Etienne University Hospital) to conduct this study and having received research support from Astute Medical unrelated to the current study. Outside the scope of this study, MD declare having received grant from MSD, speaker fees from MSD, Astelas and Gilead-Kite and having attended an advisory board for Gilead-Kite. The other authors declare having no other conflict of interest related to this manuscript.

Auteurs

David Schnell (D)

Réanimation polyvalente, CH Angoulême, Angoulême, France; Université de Strasbourg (UNISTRA), Faculté de Médecine, Hôpitaux universitaires de Strasbourg, Service de Réanimation, Nouvel Hôpital Civil, Strasbourg, France.

Aurélie Bourmaud (A)

Hygée Centre and Public Health Department, Lucien Neuwirth Cancerology Institute, Saint-Priest-en-Jarez, France.

Marie Reynaud (M)

Surgical ICU, Saint-Etienne University Hospital, Saint-Etienne, France.

Stéphane Rouleau (S)

Réanimation polyvalente, CH Angoulême, Angoulême, France.

Hamid Merdji (H)

Université de Strasbourg (UNISTRA), Faculté de Médecine, Hôpitaux universitaires de Strasbourg, Service de Réanimation, Nouvel Hôpital Civil, Strasbourg, France; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France.

Alexandra Boivin (A)

Université de Strasbourg (UNISTRA), Faculté de Médecine, Hôpitaux universitaires de Strasbourg, Service de Réanimation, Nouvel Hôpital Civil, Strasbourg, France.

Mourad Benyamina (M)

Surgical ICU and Burn Unit, Saint-Louis University Hospital, AP-HP, Paris, France.

François Vincent (F)

Medical Surgical ICU, GHIC Le Raincy-Montfermeil, 93370 Montfermeil, France.

Alexandre Lautrette (A)

Intensive Care Unit, Gabriel Montpied Hospital, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.

Christophe Leroy (C)

Intensive Care Unit, Gabriel Montpied Hospital, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.

Yves Cohen (Y)

Medical-Surgical ICU, Avicenne University Hospital, AP-HP, Bobigny, France.

Matthieu Legrand (M)

Surgical ICU and Burn Unit, Saint-Louis University Hospital, AP-HP, Paris, France; Faculté de Médecine, Université Paris-Diderot, Sorbonne-Paris-Cité, Paris, France.

Jérôme Morel (J)

Surgical ICU, Saint-Etienne University Hospital, Saint-Etienne, France; Saint-Etienne University, Jacques Lisfranc Medical School, Saint-Etienne, France.

Jeremy Terreaux (J)

Medical-Surgical ICU, Saint-Etienne University Hospital, Saint-Etienne, France; Cardiology, Saint-Etienne University Hospital, Saint-Etienne, France.

Michael Darmon (M)

Faculté de Médecine, Université Paris-Diderot, Sorbonne-Paris-Cité, Paris, France; Medical ICU, Saint-Louis University Hospital, AP-HP, Paris, France; ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153 (center of epidemiology and biostatistic Sorbonne Paris Cité, CRESS), INSERM, Paris, France. Electronic address: michael.darmon@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH